Professor Ian Young is Professor of Medicine and Director of the Centre for Public Health at Queen’s University Belfast. He is also a Consultant Chemical Pathologist and Director of Research and Development at Belfast Health and Social Care Trust, and Director of the Northern Ireland Clinical Research Network. Professor Young’s main clinical and research interests are in nutrition, lipids and their effects on disease risk, particularly in relation to the prevention of cardiovascular disease. He is an author of over 300 published research papers and is on the editorial boards of a number of leading international journals. He is a member of the UK Scientific Advisory Committee on Nutrition and Chairs the DHSSPS Obesity Prevention Steering Group. In addition, he is Chair of the Scientific Division of the International Federation for Clinical Chemistry and Laboratory Medicine
Dr .Marie Cantwell, a nutrition and cancer epidemiologist specialises in the investigation of nutritional and lifestyle factors that influence both the risk and progression of cancer including breast, prostate, oesophageal and colorectal cancer. She had published extensively on the role of diet and lifestyle on oesophageal carcinoma risk within the Factors Influencing Barrett’s Oesophagus, Reflux Oesophagitis and Oesophageal adenocarcinoma (FINBAR) study, a population-based case-control study in Ireland, and is a member of the Pooling Group for the international collaboration BEACON (Barretts Esophagus and Adenocarcinoma Consortium).
Dr Helen Coleman is currently funded by a Cancer Research UK Population Research Postdoctoral Fellowship to study the role of vitamin D and related genetic variants in colorectal cancer survival. Dr Coleman has general research interests in cancer epidemiology, particularly risk factors for progression from pre-cancerous conditions to cancer and factors associated with recurrence or survival after a cancer diagnosis, which includes the role of nutrition and nutrient*gene interactions.
Dr Valerie Holmes focuses her research on improving maternal and neonatal outcomes, with a particular interest in diabetes and pregnancy. Her research interests are in relation to how patient education and lifestyle interventions can improve outcomes. Research to date includes work on developing and evaluating educational resources in relation to preconception counselling for women with diabetes and management of gestational diabetes. Her research also investigates the potential benefit of postnatal lifestyle interventions in overweight women with a history of gestational diabetes. Dr Holmes has also a keen interest in the maternal outcome of pre-eclampsia, with research to date focusing on both prevention trials and predictive biomarkers.
Dr Jane McEneny investigates the role of inflammation and how this influences the anti-atherogenic properties of high density lipoproteins and how this may be modulated by dietary and supplement interventions. The main subject populations under investigation include those with characteristics of the metabolic syndrome, diabetes and known cardiovascular disease.
Dr Ann McGinty’s research investigates the inflammatory mechanisms underlying cardiometabolic disease, both at the whole body and the cellular level. In particular Dr McGinty’s work focuses on how adipose inflammation/dysfunction and vitamin D deficiency promote cardiometabolic disease, and on evaluating the anti-inflammatory impact of nutritional and pharmacological interventions.
Dr Michelle McKinley’s research investigates the ability of dietary interventions to modify nutritional status and risk of chronic disease, particularly diabetes and cardiovascular disease, as well as exploring novel approaches to encouraging and supporting diet and lifestyle behaviour change
Professor Jayne Woodside specialises in the conduct of human nutrition intervention studies with whole foods and whole diets, examining changes in nutritional status and in clinically relevant endpoints, and also in interventions to promote long term dietary change.